NewsRoom Articles - Page 163 of 201

TuesdayFeb 16, 2021 2:30 pm

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Outlines 2021 Business Strategies for COVID-19 PCR Testing and Psychedelic Treatments

XPhyto Therapeutics Corp. plans to commercialize its rapid and portable PCR Kit this year to provide point-of-care diagnostics The company is confident about the successful validation of the PCR kit for the European commercial (CE-IVD) approval in Q1 2021 Hugh Rogers, CEO and Director of XPhyto, revealed in the latest news release that the company will make investments and development of psychedelic treatments XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) is a bioscience accelerator involved in the development of new pharmaceuticals, diagnostic products, and psychedelic medicine. As a part of its business strategy for the year 2021, the company…

TuesdayFeb 16, 2021 11:37 am

MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FRA: 0C0) Plant-Based Biopesticide Achieves 100% Control of Root-Rot Disease in Recent Studies

Most recent tests show MustGrow’s patented biopesticide achieved 100% control over Aphanomyces within 24 hours Plant-based biopesticide uses natural defense mechanism found in mustard seed to control diseases, pests and weeds MustGrow hoping to provide valuable crop-protection tool for pulse-crop farmers MustGrow Biologics (CSE: MGRO) (OTCQX: MGROF) (FRA: 0C0) has announced that its plant-based biopesticide has achieved 100% control of root-rot disease in a recent round of laboratory tests (https://ibn.fm/dmGPy). MustGrow, an agriculture biotech company focused on providing natural science-based biological solutions for high-value crops such as fruits and vegetables, is focused on providing natural, science-based biological solutions to replace synthetic…

FridayFeb 12, 2021 3:21 pm

CNS Pharmaceuticals (NASDAQ: CNSP) Celebrates IND Status, Prepares to Launch Brain Cancer Drug Trials

Brain cancer drug developer CNS Pharmaceuticals is celebrating recent news that the U.S. Food and Drug Administration (“FDA”) granted investigational new drug (“IND”) status to CNS Pharmaceuticals’ leading candidate for fighting glioblastomas Glioblastomas are a class of aggressive brain cancers with no known cure and a median life expectancy of 14 to 16 months following diagnosis The FDA’s decision to grant CNSP’s request for IND status clears the way for the company to begin human clinical trials within the next couple of months The company’s sublicensee partner, WPD Pharmaceuticals, will also prepare a first-ever Phase I trial for drug safety…

FridayFeb 12, 2021 2:39 pm

Brain Scientific Inc. (BRSF) Establishing New Innovative Norms for Clinicians

Bergen Neurology Consultants utilized BRSF’s devices to improve patient care Minimal training means more staff can administer, monitor the EEG; more appointments can be scheduled Brain Scientific (OTCQB: BRSF), a commercial-stage, health-care company focused on developing innovative and proprietary medical devices and software, has created two devices designed to disrupt the EEG market. The NeuroCap(TM) and NeuroEEG(TM) offer cost-effective, disposable substitutes that help improve patient’s access to neurological care. The company is also helping improve the quality of care and solutions that practices can offer their patients. An example of the impact of the device can be seen through Bergen…

FridayFeb 12, 2021 11:00 am

Development on Nasal Spray That Protects Against Common Cold, Coronavirus

Research on a new drug that prepares the respiratory tract immune system against infection and is currently being developed for the coronavirus has also shown its efficacy against rhinovirus. Rhinovirus is a common respiratory infection that is responsible for aggravating chronic obstructive pulmonary disease and chronic respiratory diseases such as asthma. This respiratory virus is also the primary cause of the common cold. The researchers found that treatment with the drug INNA-X before getting infected by the rhinovirus suppressed harmful inflammation and significantly decreased viral load. Associate professor Nathan Bartlett of the Hunter Medical Research Institute and the University of…

ThursdayFeb 11, 2021 2:30 pm

Yale Researchers Develop Injection to Treat Skin Cancer

Researchers from Yale are developing an alternative treatment for skin cancer that will involve introducing nanoparticles into a cancerous tumor, thus eliminating the cancer cells in a two-stage approach. Vice chair and professor of dermatology at Yale School of Medicine Dr. Michael Girardi stated that for many patients, treating skin cancer was more important than finding an alternative but effective way to treat the disease using a simple method such as an injection. He explained that in dermatology finding an uncomplicated way to treat cancers of the skin such as basal cell carcinoma and squamous cell carcinoma was like finding…

WednesdayFeb 10, 2021 2:45 pm

Covid-19 Antibodies Found in Placentas of Infected Pregnant Women

A group of researchers with the Perelman School of Medicine at the University of Pennsylvania and the Children’s Hospital of Philadelphia, have discovered antibodies of SARS-CoV-2 in the placentas of numerous women who had tested positive for the coronavirus in the course of their pregnancies. In the study, which was reported in the “Journal of the American Medical Association,” the researchers describe their results, which were derived from assessing various women who had been infected with the coronavirus as well as their placentas after they delivered their infants. Amid the pandemic, which has continued to infect millions of individuals across…

WednesdayFeb 10, 2021 2:14 pm

Predictive Oncology Inc. (NASDAQ: POAI) Enters into Definitive Agreements for Direct Offering Totaling Estimated $3 Million

Definitive agreements with institutional, accredited investors call for issuance and sale of more than 3.5 million shares of common stock POAI currently focused on applying AI to develop personalized medical treatments, novel lab media and improved vaccines One of POAI’s highest priorities is building multi-omic predictive models of tumor drug response and outcome Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, has entered into definitive agreements with several investors for the sale of common stock (https://ibn.fm/YcBGM). The agreements with several institutional and accredited investors call for the issuance and sale…

TuesdayFeb 09, 2021 2:15 pm

Biological Sensors May Provide Physicians with Insights on Whether Treatments Are Effective

Patients suffering from potentially fatal diseases, such as cancer, may often undergo weeklong gaps that are discomforting when their courses of treatment begins. Doctors use this period to learn whether a patient’s treatment is working, and while it’s the standard way of doing things, the approach prevents health-care professionals from tracking the disease’s progression in real time. Enter Glympse Bio, a start-up that originated from Sangeeta Bhatia’s laboratory. Sangeeta Bhatia is the Marble Center for Cancer Nanomedicine director as well as an MIT Professor of Electrical Engineering and Computer Science. The start-up has developed small synthetic biosensors that can be…

MondayFeb 08, 2021 2:33 pm

United Medical Equipment Business Solutions Network Inc. Offers Rapid COVID-19 Test Designed to Identify Infection

FDA has authorized 225-plus diagnostic tests for COVID-19 since pandemic began CareStart(TM) COVID-19 antigen test received FDA authorization in July 2020 UME carries CareStart antigen kit, a powerful component of COVID-19 screening process Since the beginning of the COVID-19 pandemic, the U.S. Food and Drug Administration (“FDA”) has authorized more than 225 diagnostic tests for COVID-19 in an effort to provide growing resources to combat the disease. United Medical Equipment Business Solutions Network (“UME”), a company committed to offering a comprehensive line set of COVID-19 products, recently added one of those tests — the CareStart(TM) COVID-19 rapid antigen kit —…

News and publishing service for medical and biotechnology related companies

Contact us: 512.354.7000

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Outlines 2021 Business Strategies for COVID-19 PCR Testing and Psychedelic Treatments

MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FRA: 0C0) Plant-Based Biopesticide Achieves 100% Control of Root-Rot Disease in Recent Studies

CNS Pharmaceuticals (NASDAQ: CNSP) Celebrates IND Status, Prepares to Launch Brain Cancer Drug Trials

Brain Scientific Inc. (BRSF) Establishing New Innovative Norms for Clinicians

Development on Nasal Spray That Protects Against Common Cold, Coronavirus

Yale Researchers Develop Injection to Treat Skin Cancer

Covid-19 Antibodies Found in Placentas of Infected Pregnant Women

Predictive Oncology Inc. (NASDAQ: POAI) Enters into Definitive Agreements for Direct Offering Totaling Estimated $3 Million

Biological Sensors May Provide Physicians with Insights on Whether Treatments Are Effective

United Medical Equipment Business Solutions Network Inc. Offers Rapid COVID-19 Test Designed to Identify Infection

Official NewsWire Relationships

BioMedWire Currently Accepts

BioMedWire

Company Search

Site Search